Topical timolol for treatment of persistent granulation tissue in the setting of severe hidradenitis suppurativa by Chen, Xizhao & Guffey, Darren J
UC Davis
Dermatology Online Journal
Title
Topical timolol for treatment of persistent granulation tissue in the setting of severe 
hidradenitis suppurativa
Permalink
https://escholarship.org/uc/item/5fc1c5s5
Journal
Dermatology Online Journal, 25(11)
Authors
Chen, Xizhao
Guffey, Darren J
Publication Date
2019
License
https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0
eScholarship.org Powered by the California Digital Library
University of California
Volume 25 Number 11| November 2019| 
25(11):13 
 
 
- 1 - 
Dermatology Online Journal  ||  Letter 
Topical timolol for treatment of persistent granulation 
tissue in the setting of severe hidradenitis suppurativa 
 
Xizhao Chen1 BS, Darren J Guffey2 MD 
Affiliations: 1University of Virginia School of Medicine, Charlottesville, Virginia, USA, 2Department of Dermatology, 
University of Virginia Health System, Charlottesville, Virginia, USA 
Corresponding Author: Xizhao Chen, BS, University of Virginia School of Medicine, 200 Jeanette Lancaster Way, 
Charlottesville, VA 22903, Email: xc2nh@virginia.edu 
 
 
 
Keywords: timolol, granulation tissue, hidradenitis 
suppurativa 
 
Introduction 
Hidradenitis suppurativa (HS) is a chronic 
dermatosis with painful, deep-seated, inflamed 
nodules and sinus tracts that occur in skin bearing 
apocrine glands [1]. Mild to moderate cases are 
managed with topical antibiotics and antiseptics 
as well as intralesional corticosteroids and oral 
antibiotics [2, 3]. In severe cases, systemic 
immunosuppressive agents and surgical 
interventions are indicated. In the authors’ 
experience, dramatic improvement may occur 
when severe cases are treated with anti-tumor 
necrosis factor agents only to be complicated by 
residual granulation tissue at sites of chronically 
draining sinus tracts. We present a case in which 
large areas of granulation tissue proved 
recalcitrant to intralesional steroids and curettage 
but responded dramatically to topical timolol. 
 
Case Synopsis 
A 26-year-old man with diabetes mellitus and 
asthma presented with a 12-month history of 
debilitating HS associated with persistent 
tachycardia and a 60-pound unintentional weight 
loss. The patient had recently been admitted to 
another hospital out of concern for sepsis. Upon 
admission, the patient’s HS was managed with 
adalimumab, which was promptly discontinued 
owing to concern for sepsis. He was managed 
with serial debridement and broad-spectrum 
antibiotics without improvement. Blood and 
tissue cultures throughout his admission were 
negative.  
Abstract 
Hidradenitis suppurativa (HS) is a potentially 
debilitating dermatological disease that 
negatively impacts patients’ quality of life. Severe 
cases can be further complicated by persistent 
granulation tissue at the ostia of sinus tracts, 
which may prove recalcitrant to standard 
interventions. Herein we report such a case in 
which a patient experienced significant 
improvement from severe HS but was left with 
persistent granulation tissue that complicated his 
course of recovery. When standard interventions 
failed, we elected to begin treatment with topical 
timolol. After three months, the majority of the 
granulation tissue had regressed and has 
remained quiescent after 12 months of follow up. 
The patient has tolerated the treatment well and 
continues to use topical timolol daily as needed 
for flares. We believe that topical timolol can 
provide a practical and painless alternative to 
current invasive and expensive therapies for 
persistent granulation tissue associated with 
severe HS. 
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The patient reported painful actively draining 
nodules and sinus tracts in several areas. He had 
previously failed numerous oral antibiotics, 
topical clindamycin, and dilute bleach soaks. 
Physical examination revealed a cachectic 
appearing man in mild distress. The patient was 
tachycardic with a pulse rate of 150. Skin 
examination was notable for inflamed nodules 
and actively draining sinus tracts in bilateral 
axillae, gluteal cleft, perineum, and inguinal folds. 
Laboratory tests were remarkable for microcytic 
anemia (hemoglobin level 9.3g/dL, mean 
corpuscular volume 76μm3), leukocytosis 
(19400/μL), and thrombocytosis (576000/μL). 
Thyroid stimulating hormone level was normal. 
After reviewing his admission records, we 
suspected that the patient was never septic but 
was experiencing an HS flare despite treatment 
with adalimumab. We started the patient on 
clindamycin 1% lotion, minocycline 100mg twice 
daily, and infliximab 5mg/kg every 8 weeks. This 
resulted in resolution of his chronic tachycardia, 
anemia, and thrombocytosis. In addition, he 
experienced an 80-pound weight gain and 
dramatic improvement in his HS with resolution of 
active drainage from all previously involved areas. 
As the inflammation subsided, the patient was left 
with several areas of granulation tissue at sites of 
prior draining sinus tracts (Figure 1A). 
   
 
Figure 1. A) In October 2018, left axilla after treatment with intralesional steroids and curettage but before treatment with 
topical timolol. Note the lack of actively draining sinus tracts or inflammation, but extensive scarring and persistent exuberate 
granulation tissue.  B) In January 2019, left axilla after three months of timolol treatment. Note continued control of 
inflammation and drainage with infliximab and dramatic regression of granulation tissue after treatment with topical timolol. 
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These areas of granulation tissue bled readily and 
were quite bothersome to the patient. No 
improvement was noted with injections of 
triamcinolone 40mg/ml solution. The granulation 
tissue was also extirpated with curettage but 
quickly recurred. Having read previous reports 
regarding treatment of lobular capillary 
hemangiomas (pyogenic granulomas) with topical 
timolol, we instructed the patient to apply several 
drops of timolol 0.5% ophthalmic gel-forming 
solution to all involved areas once daily [4, 5]. In 
three months, the areas of granulation tissue had 
regressed dramatically (Figure 1B). 
 
Case Discussion 
As granulation tissue and lobular capillary 
hemangiomas are histologically similar, we 
hypothesized that both conditions might respond 
to similar interventions. Because our patient failed 
more invasive interventions, we elected to treat 
him empirically with topical timolol, which was 
highly effective and painless [4, 5]. 
Timolol is a nonselective β-adrenergic antagonist 
that can induce vasoconstriction and thus, affect 
angiogenic events to promote endothelial cell 
apoptosis. It is an effective first-line treatment for 
lobular capillary hemangiomas and infantile 
hemangioma and has been reported to promote 
healing of chronic wounds [6]. Since granulation 
tissue is highly vascular, we suspect that timolol-
induced endothelial cell apoptosis was likely the 
driving mechanism behind the regression of 
granulation tissue in this case. 
 
Conclusion 
Hidradenitis suppurativa (HS) is a chronic 
dermatosis the treatment of which can be 
complicated by residual granulation tissue 
recalcitrant to conventional therapies at sites of 
chronically draining sinus tracts. In our case, we 
found that topical timolol can provide a highly 
effective and painless treatment in patients with 
recalcitrant granulation tissue that can complicate 
treatment of severe cases of HS. Our unique case 
may contribute to the ever-expanding list of 
indications of topical beta blockers for the 
treatment of various cutaneous diseases. 
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